EX-23.1 3 ex23-1.htm EX-23.1

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form F-1 of our report dated April 2, 2025 relating to the consolidated financial statements of Galmed Pharmaceuticals Ltd. (the “Company”), appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2024. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

/s/ Brightman Almagor Zohar & Co.  

Brightman Almagor Zohar & Co.

 
Certified Public Accounts  
A Firm in the Deloitte Global Network  
   
Tel Aviv, Israel  
August 18, 2025